ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 151 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $234,000 | +875.0% | 136,136 | +288.7% | 0.00% | – |
Q1 2022 | $24,000 | -95.7% | 35,027 | -93.1% | 0.00% | – |
Q4 2021 | $556,000 | +251.9% | 508,868 | +486.2% | 0.00% | – |
Q3 2021 | $158,000 | +97.5% | 86,803 | +188.8% | 0.00% | – |
Q2 2021 | $80,000 | -87.7% | 30,055 | -83.4% | 0.00% | – |
Q1 2021 | $650,000 | +261.1% | 180,583 | +152.5% | 0.00% | – |
Q4 2020 | $180,000 | -26.5% | 71,522 | -26.6% | 0.00% | – |
Q3 2020 | $245,000 | -37.7% | 97,487 | -18.6% | 0.00% | – |
Q2 2020 | $393,000 | +148.7% | 119,782 | +84.9% | 0.00% | – |
Q1 2020 | $158,000 | -82.4% | 64,769 | -66.0% | 0.00% | – |
Q4 2019 | $898,000 | +19.6% | 190,345 | +8.6% | 0.00% | – |
Q3 2019 | $751,000 | -55.1% | 175,203 | -38.9% | 0.00% | -100.0% |
Q2 2019 | $1,671,000 | +134.4% | 286,720 | +54.9% | 0.00% | – |
Q1 2019 | $713,000 | +369.1% | 185,128 | +127.0% | 0.00% | – |
Q4 2018 | $152,000 | -66.7% | 81,562 | -43.0% | 0.00% | – |
Q3 2018 | $457,000 | +331.1% | 142,988 | +307.7% | 0.00% | – |
Q2 2018 | $106,000 | 0.0% | 35,070 | +28.6% | 0.00% | – |
Q1 2018 | $106,000 | -68.4% | 27,264 | -66.3% | 0.00% | – |
Q4 2017 | $335,000 | -8.0% | 80,932 | +36.5% | 0.00% | – |
Q3 2017 | $364,000 | +7180.0% | 59,286 | +8801.8% | 0.00% | – |
Q2 2017 | $5,000 | -80.8% | 666 | -83.9% | 0.00% | – |
Q1 2017 | $26,000 | -99.2% | 4,139 | -99.4% | 0.00% | -100.0% |
Q4 2016 | $3,450,000 | +2329.6% | 644,738 | +2441.3% | 0.00% | – |
Q3 2016 | $142,000 | +14100.0% | 25,370 | +25270.0% | 0.00% | – |
Q2 2016 | $1,000 | -98.9% | 100 | -99.3% | 0.00% | – |
Q1 2016 | $94,000 | +9300.0% | 13,354 | +8515.5% | 0.00% | – |
Q4 2015 | $1,000 | -98.4% | 155 | -97.8% | 0.00% | – |
Q3 2015 | $63,000 | -45.2% | 6,996 | -27.2% | 0.00% | – |
Q2 2015 | $115,000 | -97.8% | 9,604 | -98.1% | 0.00% | -100.0% |
Q1 2015 | $5,130,000 | +251.4% | 513,024 | +75.8% | 0.01% | +500.0% |
Q4 2014 | $1,460,000 | +298.9% | 291,822 | +59.1% | 0.00% | – |
Q3 2014 | $366,000 | -74.0% | 183,375 | -47.9% | 0.00% | -100.0% |
Q2 2014 | $1,407,000 | -66.1% | 351,666 | -66.1% | 0.00% | -80.0% |
Q1 2014 | $4,149,000 | -25.8% | 1,036,887 | -25.8% | 0.01% | -16.7% |
Q4 2013 | $5,590,000 | +78.3% | 1,397,194 | +33.7% | 0.01% | +50.0% |
Q3 2013 | $3,135,000 | +119.8% | 1,045,096 | +54.6% | 0.00% | +100.0% |
Q2 2013 | $1,426,000 | – | 675,967 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 15,151,516 | $49,697,000 | 12.67% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 9,642,760 | $31,628,000 | 5.74% |
MILLER VALUE PARTNERS, LLC | 12,619,730 | $41,393,000 | 1.84% |
MAGNOLIA CAPITAL ADVISORS LLC | 90,585 | $297,000 | 0.38% |
Sargent Investment Group, LLC | 232,025 | $759,000 | 0.28% |
Old West Investment Management, LLC | 210,583 | $690,000 | 0.20% |
Virtus ETF Advisers LLC | 112,619 | $369,000 | 0.18% |
tru Independence LLC | 213,712 | $701,000 | 0.10% |
AIGEN INVESTMENT MANAGEMENT, LP | 180,297 | $591,000 | 0.08% |
Golden State Wealth Management, LLC | 90,585 | $297,000 | 0.08% |